company

SENSE BIOPHARMA AS

0154 OSLO

Return on Equity
382,73 %
Current Ratio
0,14
Debt-to-Equity Ratio
−0
Key figures (NOK)2020
Revenue0
Net Income−10 437 000
Total Assets440 000
Total Equity−2 727 000
Income (NOK)2020
Revenue0
Expenditure10 304 000
Operating Profit−10 304 000
Financial Income2 000
Financial Costs134 000
Financial Balance−132 000
Earnings Before Tax−10 437 000
Tax0
Net Income−10 437 000
Balance (NOK)2020
Total Fixed Assets12 000
Total Current Assets428 000
Total Assets440 000
Total Retained Equity−16 370 000
Total Equity−2 727 000
Total Long-Term Debt0
Total Current Debt3 167 000
Total Equity and Debt440 000
Cash flow (NOK)2020
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs3 101 000
Depreciation6 000
Impairment0
Expenditure10 304 000
Operating Profit−10 304 000
Financial Income2 000
Financial Costs134 000
Financial Balance−132 000
Dividends0
Net Income−10 437 000
Balance details (NOK)2020
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures12 000
Total Tangible Assets12 000
Total Fiancial Fixed Assets0
Total Fixed Assets12 000
Stock0
Total Investments0
Cash, Bank380 000
Total Current Assets428 000
Total Assets440 000
Total Equity−2 727 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors407 000
Unpaid Taxes251 000
Dividends0
Other Current Debt2 509 000
Total Current Debt3 167 000
Total Equity and Debt440 000
Financial indicators2020
Return on Equity382,73 %
Debt-to-Equity Ratio−0
Operating Profit Margin-
Current Ratio0,14
Quick Ratio0,14
Equity Ratio−6,2
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English